Welcome to AIDS Action Europe
News
Call for Interest: AIDS Action Europe Visual Identity Relaunch
Call for Interest - Training of Trainers on Harm Reduction in the Context Chemsex
Survey on HPV and related cancers: prevention, testing and screening among PLHIV and key populations
Events
EU Health Policy Platform Annual Meeting – Stakeholders’ Dialogue: Joint Statements, Study results and discussion
Thematic Network on HIV, TB, viral hepatitis, and STIs: Eliminating Stigma, Discrimination and Criminalisation of Key Populations - Webinar
EU HIV/AIDS, viral hepatitis and Tuberculosis Civil Society Forum. June 2022
Publications
AAE Poster "Legal and Policy Barriers to the Provision of Community-based testing services in Europe and Central Asia"
At HepHIV 2023, AAE presented the poster "Legal and Policy Barriers to the Provision of Community-based testing services in Europe and Central Asia"
The poster is a result of the project Community Led and Based HIV Services - Key to Ending the HIV Epidemic in Europe and Central Asia which was developed in partnership with CEEISCAT and LILA Milano and ran for 20 months in 2022-2023. The project focused on increasing, adapting, and improving community based testing services for HIV/AIDS, viral hepatitis and other sexually-transmitted infections in Europe and Central Asia.
AAE Poster “HIV Criminalisation in the EU: a Comparative 20 country report”
At HepHIV 2023, AAE presented the poster “HIV Criminalisation in the EU: a Comparative 20 country report”. The poster is based on the EHLF HIV Criminalisation report, which was developed in two phases.
Prevention and control of infectious diseases among people who inject drugs
This joint guidance by the European Centre for Disease Prevention and Control (ECDC) and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) aims to support policy-makers and public health/social programme planners by providing an evidence base for developing national strategies, policies, and programmes for preventing and controlling infections and infectious diseases among people who inject drugs. It also provides practice considerations and aims to inform the monitoring and evaluation of prevention and control strategies, policies, and programmes.